Oaktree Acquisition Corp. III Life Sciences Warrant (OACCW) is a special purpose acquisition company (SPAC) targeting high-growth opportunities within the life sciences sector. Backed by Oaktree Capital Management, a premier global investment firm, OACCW seeks to leverage its extensive industry expertise and resources to drive innovation and operational excellence in healthcare. This warrant presents a strategic investment opportunity for institutional investors looking to gain exposure to the rapidly expanding life sciences market, supported by Oaktree's deep insights and robust network within the industry.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 115.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.37M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting